PEOPLE - Changes at Urologix (US):
This article was originally published in Clinica
Urologix (Minneapolis, Minnesota), a developer, manufacturer and marketer of minimally invasive urological products, has announced the resignations of board members Paul LaViolette and Eric Simon. Mr LaViolette will continue to serve Boston Scientific's cardiovascular business and Mr Simon intends to focus on other business initiatives at Lyon, France-based EDAP. Urologix does not plan to appoint replacements.